Table 4.

Time to brain progression (TTBP) and overall survival (OS) according to the type of treatment for brain metastases

	Surgery-SRS 88 pts	WBRT 136 pts	Chemotherapy 66 pts
BPFa survival at 1 year	80 %	76 %	62 %
BPF survival at 2 years	71 %	53.5 %	34 %
median TTBP	27 months	25 months	14 months
	(C.I. 95%:16-21)	(C.I. 95%:20-30)	(C.I. 95%:11-17)
1 year OS	74.9 %	47.3 %	33.6 %
2 years OS	42.1 %	23 %	11.5 %
median OS	18 months	10 months	8 months
	(C.I. 95%:26-28)	(C.I. 95%:7-14)	(C.I. 95%:7-10)

^aBrain Progression Free Survival